Foghorn Therapeutics Statistics
Total Valuation
FHTX has a market cap or net worth of $289.39 million. The enterprise value is $171.77 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FHTX has 58.70 million shares outstanding. The number of shares has increased by 14.72% in one year.
| Current Share Class | 58.70M |
| Shares Outstanding | 58.70M |
| Shares Change (YoY) | +14.72% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 7.49% |
| Owned by Institutions (%) | 38.32% |
| Float | 28.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.36 |
| Forward PS | 9.30 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73
| Current Ratio | 2.73 |
| Quick Ratio | 2.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -21.29% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -59.34% |
| Weighted Average Cost of Capital (WACC) | 18.70% |
| Revenue Per Employee | $291,594 |
| Profits Per Employee | -$700,783 |
| Employee Count | 106 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.07% in the last 52 weeks. The beta is 3.11, so FHTX's price volatility has been higher than the market average.
| Beta (5Y) | 3.11 |
| 52-Week Price Change | +46.07% |
| 50-Day Moving Average | 5.41 |
| 200-Day Moving Average | 5.09 |
| Relative Strength Index (RSI) | 46.24 |
| Average Volume (20 Days) | 191,965 |
Short Selling Information
The latest short interest is 1.28 million, so 2.19% of the outstanding shares have been sold short.
| Short Interest | 1.28M |
| Short Previous Month | 1.18M |
| Short % of Shares Out | 2.19% |
| Short % of Float | 4.48% |
| Short Ratio (days to cover) | 8.30 |
Income Statement
In the last 12 months, FHTX had revenue of $30.91 million and -$74.28 million in losses. Loss per share was -$1.18.
| Revenue | 30.91M |
| Gross Profit | -54.56M |
| Operating Income | -82.11M |
| Pretax Income | -74.28M |
| Net Income | -74.28M |
| EBITDA | -78.78M |
| EBIT | -82.11M |
| Loss Per Share | -$1.18 |
Full Income StatementBalance Sheet
The company has $158.89 million in cash and $41.27 million in debt, with a net cash position of $117.62 million or $2.00 per share.
| Cash & Cash Equivalents | 158.89M |
| Total Debt | 41.27M |
| Net Cash | 117.62M |
| Net Cash Per Share | $2.00 |
| Equity (Book Value) | -108.50M |
| Book Value Per Share | -1.92 |
| Working Capital | 103.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$86.10 million and capital expenditures -$50,000, giving a free cash flow of -$86.15 million.
| Operating Cash Flow | -86.10M |
| Capital Expenditures | -50,000 |
| Depreciation & Amortization | 3.33M |
| Net Borrowing | n/a |
| Free Cash Flow | -86.15M |
| FCF Per Share | -$1.47 |
Full Cash Flow StatementMargins
Gross margin is -176.51%, with operating and profit margins of -265.64% and -240.33%.
| Gross Margin | -176.51% |
| Operating Margin | -265.64% |
| Pretax Margin | -240.33% |
| Profit Margin | -240.33% |
| EBITDA Margin | -254.86% |
| EBIT Margin | -265.64% |
| FCF Margin | n/a |
Dividends & Yields
FHTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.72% |
| Shareholder Yield | -14.72% |
| Earnings Yield | -25.67% |
| FCF Yield | -29.77% |
Analyst Forecast
The average price target for FHTX is $11.50, which is 133.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 133.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 32.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FHTX has an Altman Z-Score of -4.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.54 |
| Piotroski F-Score | 2 |
